Hepatitis C Relapse
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Direct Acting Agents in Hepatitis C Patients (NCT03145844) | Fehmi Tabak | 2017-04-09 |
| Impact of Interleukin 28B (rs12979860) Genotype on Virological Responses Chronic Hepatitis C Treatment (NCT03090035) | Sheikh Zayed Medical College | 2014-01-01 |
Track Hepatitis C Relapse automatically
Every clearance here is in the API, with alerts when new ones post.